
201 - 500 employees
💊 Pharmaceuticals
🏥 Healthcare
🏭 Manufacturing
💰 $100M Post-IPO Debt on 2023-03
Pharmaceuticals • Healthcare • Manufacturing
Harrow is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable and accessible medications. The company closely listens to the needs of providers and their patients, aiming to deliver high-quality products and services. With a remarkable 72% compound annual growth rate over its first eight years, Harrow stands out as one of the fastest-growing ophthalmic pharmaceutical companies in the United States.
Selected: 🆕 Date Added.
🔥 2 hours ago
Pharmacovigilance Associate supporting adverse-event reporting and regulatory safety compliance for Harrow’s ophthalmic pharmaceutical portfolio. Processing ICSRs, FDA submissions, and aggregate safety reports.
🏖️ New Jersey – Remote
💰 $100M Post-IPO Debt on 2023-03
⏰ Full Time
🟢 Junior
🟡 Mid-level
✨ Associate
👻 Ghost score 15%